Efficacy and Safety of 24 Weeks of Oral Treatment With BIIL 284 BS in Adult and Pediatric Patients

Clinical trial NCT00060801 · TERMINATED

Trial details

NCT number: NCT00060801
Sponsor: Boehringer Ingelheim
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Cystic Fibrosis

Start date: 2003-05-01
Primary completion: 2004-07-01
Enrollment: 420

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.